Softgel

Europe Starch Softgel Capsules Market Forecast to 2027 - Covid-19 Impact and Analysis - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 9, 2020
Pharmaceutical, Health, Fitness & Nutrition, Health, Articles, Pharmacology, Dosage forms, Nutrition, Pharmaceutical industry, Capsule, Dietary supplement, Food science, Starch, Softgel, Nutraceutical

The "Europe Starch Softgel Capsules Market Forecast to 2027 - Covid-19 Impact and Analysis - by Application (Pharmaceutical, Health Supplements, Others); Distribution Channel (Supermarket and Hypermarket, Pharmacy and Drugstore, Online Provider)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Starch Softgel Capsules Market Forecast to 2027 - Covid-19 Impact and Analysis - by Application (Pharmaceutical, Health Supplements, Others); Distribution Channel (Supermarket and Hypermarket, Pharmacy and Drugstore, Online Provider)" report has been added to ResearchAndMarkets.com's offering.
  • The Europe starch softgel capsules market is expected to reach US$ 161.36 million by 2027 from US$ 114.85 million in 2019.
  • The growth of the Europe starch softgel capsules market is attributed to increasing availability of vegetarian softgel capsules and rising preference of pharmaceutical and nutraceutical companies toward softgel capsules.
  • Based on application, the Europe starch softgel capsules market is segmented into pharmaceutical, health supplements, and others.

Asia Pacific Starch Softgel Capsules Market Forecast to 2027 - Covid-19 Impact and Regional Analysis - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 9, 2020
Pharmaceutical, Health, Medical Supplies, Health, Pharmacology, Dosage forms, Capsule, Pharmaceutical industry, Starch, Softgel, Dietary supplement

The Asia Pacific starch softgel capsule market is expected to reach US$ 122.54 million by 2027 from US$ 82.55 million in 2019.

Key Points: 
  • The Asia Pacific starch softgel capsule market is expected to reach US$ 122.54 million by 2027 from US$ 82.55 million in 2019.
  • Thus, growing healthcare industry in countries in Asia Pacific is likely to fuel the starch softgel capsules market in the region.
  • Based on application, the Asia Pacific starch softgel capsules market is segmented into pharmaceutical, health supplements, and others.
  • 7.2 Starch Softgel Capsules Market Share, By Application, 2019 & 2027 (%)
    8.2 Starch Softgel Capsules Market Share, By Distribution Channel, 2019 & 2027 (%)

Astaxanthin Market Size Worth $3.4 Billion By 2027 | CAGR: 16.2%: Grand View Research, Inc.

Retrieved on: 
Wednesday, September 2, 2020
Health, Articles, Pharmacology, Dosage forms, Carotenoids, Food colorings, Astaxanthin, Capsule, Softgel, Nutraceutical

The softgel capsules segment is expected to witness lucrative growth over the forecast period due to rapidly gaining acceptance as oral nutraceutical.

Key Points: 
  • The softgel capsules segment is expected to witness lucrative growth over the forecast period due to rapidly gaining acceptance as oral nutraceutical.
  • Major players are focusing on new product development and collaborative agreements to meet the increasing demand for the carotenoid in aquaculture.
  • Thus, increased adoption of the carotenoid in the aforementioned applications is anticipated to drive the market.
  • Grand View Research has segmented the global astaxanthin market on the basis of source, product, application, and region:

Astaxanthin Market Size Worth $3.4 Billion By 2027 | CAGR: 16.2%: Grand View Research, Inc.

Retrieved on: 
Wednesday, September 2, 2020
Health, Articles, Pharmacology, Dosage forms, Carotenoids, Food colorings, Astaxanthin, Capsule, Softgel, Nutraceutical

The softgel capsules segment is expected to witness lucrative growth over the forecast period due to rapidly gaining acceptance as oral nutraceutical.

Key Points: 
  • The softgel capsules segment is expected to witness lucrative growth over the forecast period due to rapidly gaining acceptance as oral nutraceutical.
  • Major players are focusing on new product development and collaborative agreements to meet the increasing demand for the carotenoid in aquaculture.
  • Thus, increased adoption of the carotenoid in the aforementioned applications is anticipated to drive the market.
  • Grand View Research has segmented the global astaxanthin market on the basis of source, product, application, and region:

BlosumCBD's Softgel Capsules Lets Users Take CBD Effortlessly

Retrieved on: 
Thursday, August 13, 2020
Drugs, Pharmacology, Dosage forms, Health, Capsule, Softgel, Cannabidiol, Central Business District, Singapore

The downside of reaping the CBD oil benefits is having to do mental gymnastics to figure out how much CBD oil you've been giving yourself.

Key Points: 
  • The downside of reaping the CBD oil benefits is having to do mental gymnastics to figure out how much CBD oil you've been giving yourself.
  • BlosumCBD solved this problem by letting their customers eat their cake and have it, too, with the brand's CBD Softgels 25 mg. Customers can shop via their online store .
  • These CBD softgels allow a seamless and effortless way to get the appropriate daily CBD dosage without the hassle of dosing.
  • BlosumCBD's Softgel Capsules are formulated with pure and organic ingredients, so customers know they're getting some of the best CBD products in the market.

Catalent Adds Potent Manufacturing Capabilities at its Buenos Aires, Argentina Site

Retrieved on: 
Tuesday, August 4, 2020
Life sciences, Biotechnology, Articles, Catalent, Gene therapy, Dosage forms, Pharmaceutical industry, Softgel, Biopharmaceutical

The expansion, which will add over 11,000 square feet of production space at the facility, will be segregated and designed to handle cytotoxic and highly active products for prescription softgel manufacturing.

Key Points: 
  • The expansion, which will add over 11,000 square feet of production space at the facility, will be segregated and designed to handle cytotoxic and highly active products for prescription softgel manufacturing.
  • This will add a capacity of over 10 million doses per annum to the site, which supplies products to the Latin American, U.S. and European markets.
  • Catalent's 265,000 square-foot-facility in Buenos Aires currently houses softgel manufacturing operations, providing customers with a full range of development services, from formulation to packaging.
  • Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products.

Catalent Expands Beauty and Plant-Based Consumer Health Softgel Capabilities at its Facilities in Canada and Brazil

Retrieved on: 
Tuesday, June 30, 2020
Dosage forms, Pharmacology, Health, Catalent, Pharmaceutical sciences, Softgel, Capsule

The expansion projects include new softgel encapsulation lines at each site, dedicated to Catalent's proprietary Vegicaps plant-based capsule and CosmoPod twist-off capsule technologies.

Key Points: 
  • The expansion projects include new softgel encapsulation lines at each site, dedicated to Catalent's proprietary Vegicaps plant-based capsule and CosmoPod twist-off capsule technologies.
  • "We have seen increased consumer demand for greater product choice, with sales of plant-based softgel technologies growing by more than 25% globally in recent years.
  • Additionally, Brazil has grown to become the world's fourth-largest market for beauty care products," commented Dr. Aris Gennadios, President, Softgel & Oral Technologies, Catalent.
  • Catalent partners with 23 of the top 25 consumer health companies and produces more than 5,000 consumer health and beauty products, which are marketed in more than 70 countries.

ISDIN Announces The Launch Of SunISDIN™ Softgel Capsules

Retrieved on: 
Wednesday, April 29, 2020
Dosage forms, Pharmacology, Health, Capsule, Pharmaceutical industry, Softgel

MORRISTOWN, N.J., April 29, 2020 /PRNewswire/ -- Spain's No.1 dermatological company, ISDIN, announces today the launch of SunISDIN Softgel Capsules to the U.S. market.

Key Points: 
  • MORRISTOWN, N.J., April 29, 2020 /PRNewswire/ -- Spain's No.1 dermatological company, ISDIN, announces today the launch of SunISDIN Softgel Capsules to the U.S. market.
  • SunISDIN comes in a softgel capsule that is taken once daily with plenty of water.
  • The supplement retails for $49.95 (30 capsules) and is now available through select dermatologists, or online at www.isdin.com/us.
  • Founded in 1975 and headquartered in Barcelona, Spain, ISDIN is an International laboratory specialized in innovative solutions for major dermatological needs and pathologies.

Xtracted CBD Raises the bar for Purity and Transparency in the CBD Industry

Retrieved on: 
Wednesday, December 11, 2019
Drugs, Materials, Health, Cannabinoids, Entheogens, Euphoriants, Biofuels, Hemp, Herbs, Cannabidiol, Softgel, Cannabis

Xtracted currently offers oil tinctures, gummies, softgels, topicals, and even freeze-dried cat and dog treats for sale on XtractedCBD.com.

Key Points: 
  • Xtracted currently offers oil tinctures, gummies, softgels, topicals, and even freeze-dried cat and dog treats for sale on XtractedCBD.com.
  • We want to make sure people understand the potential benefits of CBD, how it works, and the relative advantages of the various delivery methods."
  • Xtracted CBD, LLC produces and sells organic, full-spectrum CBD oil tinctures, gummies, softgels, topicals, and freeze-dried treats for pets.
  • Xtracted CBD products use pure CBD oil sourced from organic, American-grown hemp, and do not have any psychoactive side effects.